In Vitro Antifungal Combination of Terbinafine with Itraconazole against Isolates of Trichophyton Species

Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0144921. doi: 10.1128/AAC.01449-21. Epub 2021 Oct 11.

Abstract

Terbinafine is used as the first-line therapy for dermatophytosis, but the incidence of terbinafine resistance is increasing. A combination of terbinafine with itraconazole was tested using the checkerboard method based on the EUCAST methodology for antifungal susceptibility testing against 9 terbinafine-susceptible and 7 terbinafine-resistant clinical isolates of Trichophyton spp. from India. Synergistic interactions were observed for 4/9 of the susceptible isolates, with fractional inhibitory concentration index (FICI) values of 0.3125 to 0.5, and for 4/7 of the resistant isolates, with FICI values of 0.032 to 0.3125.

Keywords: EUCAST; Trichophyton; antifungal combination; dermatophytes; itraconazole; terbinafine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology
  • Arthrodermataceae*
  • Itraconazole / pharmacology
  • Microbial Sensitivity Tests
  • Terbinafine / pharmacology
  • Trichophyton*

Substances

  • Antifungal Agents
  • Itraconazole
  • Terbinafine